Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tuberculosis in older adults: challenges and best practices in the Western Pacific Region
Alvin Kuo Jing Teo, Fukushi Morishita, Tauhid Islam, et al.
The Lancet Regional Health - Western Pacific (2023) Vol. 36, pp. 100770-100770
Open Access | Times Cited: 20

Showing 20 citing articles:

The Impact of Immune System Aging on Infectious Diseases
Eugenia Quirós-Roldán, Alessandra Sottini, Pier Giorgio Natali, et al.
Microorganisms (2024) Vol. 12, Iss. 4, pp. 775-775
Open Access | Times Cited: 26
The Western Pacific Regional Framework to End TB: overview and critical reflection
Kyunghwan Oh, Fukushi Morishita, Kalpeshsinh Rahevar, et al.
Deleted Journal (2025) Vol. 2, Iss. 2, pp. 64-72
Open Access | Times Cited: 2
Community-based active-case finding for tuberculosis: navigating a complex minefield
Peter MacPherson, Kwame Shanaube, Mphatso D. Phiri, et al.
BMC Global and Public Health (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 10
Changing epidemic of tuberculosis amidst the COVID-19 pandemic in the Western Pacific Region: analysis of tuberculosis case notifications and treatment outcomes from 2015 to 2022
Kyung Hyun Oh, Manami Yanagawa, Fukushi Morishita, et al.
The Lancet Regional Health - Western Pacific (2024) Vol. 47, pp. 101104-101104
Open Access | Times Cited: 5
Effectiveness and safety of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis: a prospective cohort study
Oleksandr Korotych, Jay Achar, Elmira Gurbanova, et al.
The Lancet Infectious Diseases (2024)
Open Access | Times Cited: 5
Integrating narrative and bibliometric approaches to examine factors and impacts of tuberculosis treatment non-compliance
Agus Santosa, Neti Juniarti, Tuti Pahria, et al.
Multidisciplinary Respiratory Medicine (2025) Vol. 20, Iss. Vol. 20 (2025)
Open Access
Risk factors for latent tuberculosis infection clustering among the elderly: a population-based cross-sectional study in Eastern China
Zhenguo Zhu, Libin Chen, Jiajun Hu, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
Policy Impediments to Tuberculosis Elimination: Consequences of an Absent Medicare National Coverage Determination for Tuberculosis Prevention
Matthew Murrill, Katya Salcedo, Cynthia A. Tschampl, et al.
Journal of Immigrant and Minority Health (2025)
Open Access
Is convenience really king? Comparative evaluation of catastrophic costs due to tuberculosis in the public and private healthcare sectors of Viet Nam: a longitudinal patient cost study
Hoa Binh Nguyen, Luan Nguyen Quang Vo, Rachel Jeanette Forse, et al.
Infectious Diseases of Poverty (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 3
The temporal trend of tuberculosis burden in an aging population in China: a secondary data analysis from the GBD 2019
Beibei Che, Xubin Zheng, Bin Chen, et al.
BMC Pulmonary Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Health at a Glance: Asia/Pacific 2024

Health at a glance. Asia/Pacific (2024)
Open Access | Times Cited: 2
Genomic characteristics of prospectively sequenced Mycobacterium tuberculosis from respiratory and non-respiratory sources
Xiaomei Zhang, Connie Lam, Eby Sim, et al.
iScience (2024) Vol. 27, Iss. 7, pp. 110327-110327
Open Access | Times Cited: 1
Representativeness and adverse event reporting in late-phase clinical trials for rifampin-susceptible tuberculosis: a systematic review
William J. Burman, Pauline Luczynski, C. Robert Horsburgh, et al.
The Lancet Infectious Diseases (2024)
Closed Access | Times Cited: 1
Immune aging and infectious diseases
Ruochan Chen, Zou Ju, Jun Chen Chen, et al.
Chinese Medical Journal (2024)
Open Access | Times Cited: 1
Community-Wide Active Case Finding for Tuberculosis: Time to Use the Evidence We Have
Mikaela Coleman, Christopher Lowbridge, Philipp du Cros, et al.
Tropical Medicine and Infectious Disease (2024) Vol. 9, Iss. 9, pp. 214-214
Open Access
Elderly age and tuberculosis: diagnostics difficulties and course features
О. М. Raznatovska, О.S. Shalmin, R.M. Yasinskyi, et al.
Infusion & Chemotherapy (2024), Iss. 3, pp. 41-44
Open Access
Differences in clinical, radiological and laboratory parameters between elderly and young patients with newly diagnosed smear‐positive pulmonary tuberculosis in Vietnam
Khanh Linh Duong, Duc M. Bui, K. Dang, et al.
Tropical Medicine & International Health (2024) Vol. 30, Iss. 1, pp. 51-56
Closed Access
Ending tuberculosis: challenges and opportunities
Beth Gilmour, Kefyalew Addis Alene
Frontiers in Tuberculosis (2024) Vol. 2
Open Access
Timing and predictors of death during treatment in patients with multidrug/rifampin-resistant tuberculosis in South Korea
Eunjeong Son, Hongjo Choi, Jeongha Mok, et al.
The Korean Journal of Internal Medicine (2024) Vol. 39, Iss. 4, pp. 640-649
Open Access
A life that’s worth living – measuring health-related quality of life among people treated for tuberculosis in Viet Nam: a longitudinal EQ-5D-5L survey
Luan Nguyen Quang Vo, Rachel Jeanette Forse, Andrew James Codlin, et al.
Research Square (Research Square) (2024)
Open Access
Page 1

Scroll to top